Does TRIMIPRAMINE Cause Agranulocytosis? 5 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Agranulocytosis have been filed in association with TRIMIPRAMINE (Trimipramine Maleate). This represents 0.7% of all adverse event reports for TRIMIPRAMINE.
5
Reports of Agranulocytosis with TRIMIPRAMINE
0.7%
of all TRIMIPRAMINE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Agranulocytosis From TRIMIPRAMINE?
Of the 5 reports, 1 (20.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
Yes, Agranulocytosis is listed as a known adverse reaction in the official FDA drug label for TRIMIPRAMINE.
What Other Side Effects Does TRIMIPRAMINE Cause?
Toxicity to various agents (85)
Off label use (66)
Somnolence (64)
Nausea (60)
Coma (59)
Dizziness (58)
Drug abuse (57)
Abdominal pain upper (46)
Headache (46)
Vomiting (45)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which TRIMIPRAMINE Alternatives Have Lower Agranulocytosis Risk?
TRIMIPRAMINE vs TRIPROLIDINE
TRIMIPRAMINE vs TRIPTORELIN
TRIMIPRAMINE vs TRISODIUM
TRIMIPRAMINE vs TROFINETIDE
TRIMIPRAMINE vs TROFOSFAMIDE